AU3324100A - Use of pirenoxine for the protection of corneal tissues in photokeratectomy - Google Patents

Use of pirenoxine for the protection of corneal tissues in photokeratectomy

Info

Publication number
AU3324100A
AU3324100A AU33241/00A AU3324100A AU3324100A AU 3324100 A AU3324100 A AU 3324100A AU 33241/00 A AU33241/00 A AU 33241/00A AU 3324100 A AU3324100 A AU 3324100A AU 3324100 A AU3324100 A AU 3324100A
Authority
AU
Australia
Prior art keywords
pirenoxine
photokeratectomy
protection
cornea
corneal tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33241/00A
Other languages
English (en)
Inventor
Enrico Boldrini
Mario Ciuffi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmigea SpA
Original Assignee
Farmigea SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea SpA filed Critical Farmigea SpA
Publication of AU3324100A publication Critical patent/AU3324100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU33241/00A 1999-03-17 2000-03-13 Use of pirenoxine for the protection of corneal tissues in photokeratectomy Abandoned AU3324100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM99A0166 1999-03-17
IT1999RM000166A IT1305306B1 (it) 1999-03-17 1999-03-17 Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.
PCT/IT2000/000081 WO2000054757A2 (en) 1999-03-17 2000-03-13 Use of pirenoxine for the protection of corneal tissues in photokeratectomy

Publications (1)

Publication Number Publication Date
AU3324100A true AU3324100A (en) 2000-10-04

Family

ID=11406570

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33241/00A Abandoned AU3324100A (en) 1999-03-17 2000-03-13 Use of pirenoxine for the protection of corneal tissues in photokeratectomy

Country Status (10)

Country Link
US (1) US6610686B1 (https=)
EP (1) EP1173255B1 (https=)
JP (1) JP5167499B2 (https=)
AT (1) ATE349244T1 (https=)
AU (1) AU3324100A (https=)
DE (1) DE60032594T2 (https=)
ES (1) ES2277831T3 (https=)
IT (1) IT1305306B1 (https=)
PT (1) PT1173255E (https=)
WO (1) WO2000054757A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655002B2 (en) * 1996-03-21 2010-02-02 Second Sight Laser Technologies, Inc. Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation
US9545338B2 (en) 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
US10842675B2 (en) 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US9889043B2 (en) 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
US8500723B2 (en) 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures
US8480659B2 (en) 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
US8382745B2 (en) 2009-07-24 2013-02-26 Lensar, Inc. Laser system and method for astigmatic corrections in association with cataract treatment
CA2769090A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for providing laser shot patterns to the lens of an eye
US8758332B2 (en) 2009-07-24 2014-06-24 Lensar, Inc. Laser system and method for performing and sealing corneal incisions in the eye
US8617146B2 (en) 2009-07-24 2013-12-31 Lensar, Inc. Laser system and method for correction of induced astigmatism
WO2011011788A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for performing ladar assisted procedures on the lens of an eye
CN102843955A (zh) 2010-02-01 2012-12-26 雷萨公司 眼科应用中吸环基于浦肯野图像的对准
USD694890S1 (en) 2010-10-15 2013-12-03 Lensar, Inc. Laser system for treatment of the eye
USD695408S1 (en) 2010-10-15 2013-12-10 Lensar, Inc. Laser system for treatment of the eye
ES3064580T3 (en) 2010-10-15 2026-04-27 Lensar Inc Scan-controlled illumination of structures within an eye
US10463541B2 (en) 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
EP2800812A1 (en) * 2012-01-04 2014-11-12 Quark Pharmaceuticals, Inc. Double-stranded rna compounds to casp2 and uses thereof
CN103211754A (zh) * 2012-01-19 2013-07-24 武汉诺安药业有限公司 无菌稳定的吡诺克辛钠滴眼液的生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2181788A1 (en) * 1994-01-21 1995-07-27 Jonathan Javitt Cis-hydroxyproline analogs for eye treatment
WO1998053806A1 (en) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
IT1292103B1 (it) * 1997-06-06 1999-01-25 Pharmaconsult S A S Composizioni farmaceutiche topiche contenenti pirfenossone e uso dello stesso nel trattamento di condizioni infiammatorie
CN1291898A (zh) * 1998-02-25 2001-04-18 若素制药株式会社 用于角膜上皮疾病的药物

Also Published As

Publication number Publication date
ATE349244T1 (de) 2007-01-15
EP1173255B1 (en) 2006-12-27
ES2277831T3 (es) 2007-08-01
US6610686B1 (en) 2003-08-26
WO2000054757A3 (en) 2001-03-29
IT1305306B1 (it) 2001-05-04
WO2000054757A2 (en) 2000-09-21
DE60032594D1 (de) 2007-02-08
DE60032594T2 (de) 2007-10-11
EP1173255A2 (en) 2002-01-23
PT1173255E (pt) 2007-03-30
ITRM990166A1 (it) 2000-09-17
JP5167499B2 (ja) 2013-03-21
JP2002539153A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
AU3324100A (en) Use of pirenoxine for the protection of corneal tissues in photokeratectomy
EP1514548A3 (en) Use of cloprostenol fluprostenol, and their analogues to treat glaucoma and ocular hypertension
ES2152556T3 (es) Composiciones que contienen derivados del acido hidroperoxieicosatetraenoico y procedimientos de utilizacion en el tratamiento de trastornos de la sequedad ocular.
AU3806199A (en) Administration of resveratrol to prevent or treat restenosis following coronary intervention
AU3850600A (en) Dalda analogs and their use
WO2002009702A3 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
CA2321560A1 (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
PL330768A1 (en) Perpetration for use in therapy and prophylactics of dermatological diseases
DK1173198T3 (da) Anvendelse af en bestemt hyaluronidase til eliminering af ar på, uigennemsigtighed og uklarhed på hornhinden
CA2468664A1 (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
AU2001278708A1 (en) Adenosine derivatives and use thereof
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
WO1998024898A3 (en) Therapeutic composition comprising the kal protein and use of the kal protein
AU1860895A (en) Drug for relieving side effects caused by immunosuppressants
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
ATE352317T1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
CA2266363A1 (en) Corneal subepithelial opacity inhibitor
CA2066842A1 (en) Corneal treatment agents
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase